NewConnect

NewConnect is an alternative equity market operated by the Warsaw Stock Exchange (WSE) in Poland. It was created to give smaller companies, particularly young businesses with growth ambitions, access to public equity financing without requiring them to meet all of the cost, scale, reporting, and admission burdens associated with the WSE's main regulated market. The market is structured as a multilateral trading facility outside the regulated market framework. The first NewConnect trading session took place on 30 August 2007. Its development drew on established junior-market models, especially London's Alternative Investment Market and the Nordic First North markets. The concept was to create a public venue that could bridge the gap between private financing and a full-scale stock-market listing. Companies using the venue could obtain visibility, broaden their shareholder base, and raise capital while operating under comparatively simplified entry and reporting arrangements. Relative to the WSE main market, NewConnect has generally been positioned around lower flotation costs, less demanding admission criteria, and more limited ongoing reporting requirements. These characteristics make it relevant to smaller issuers whose businesses may still be developing, but they also mean that investors must assess companies with potentially shorter operating histories, lower liquidity, and greater business risk. The market therefore functions both as a financing channel and as a possible stepping stone for companies that later seek admission to the WSE main market. NewConnect is not a conventional consumer-facing product brand. Its brand represents a market infrastructure and listing framework: it connects issuers, investors, authorised advisers, brokers, and the WSE's trading and disclosure systems. Its typical participants are Polish companies, although foreign issuers can also be admitted. The market has been associated with sectors in which smaller high-growth companies are common, including technology, life sciences, biotechnology, and other emerging industries. The market maintains dedicated performance indicators. NCIndex is designed as a broad measure covering companies listed on NewConnect. NSX Life Science tracks companies from pharmaceutical and biotechnology sectors. These indices provide reference points for monitoring the performance of the market and selected industry participants, although they are not themselves separate trading venues. As of November 2021, the market had 376 listed companies and aggregate market capitalisation of approximately PLN 18.862 billion, according to the cited Wikipedia reference. Almost all listed companies were based in Poland, with four foreign companies reported at that time. These figures are historical and should not be treated as current market statistics without a newer source. NewConnect's strategic role is to support the development of Poland's entrepreneurial and capital-market ecosystem. It gives smaller businesses a public-market route while providing investors with access to companies earlier in their corporate life cycles than those typically found on a mature regulated exchange. The model involves a trade-off: simplified access and lower costs can improve financing availability, but smaller issuers may also exhibit limited liquidity, higher volatility, and greater disclosure and execution risk than established main-market companies.

NewConnect was established by the Warsaw Stock Exchange as a dedicated market for smaller companies seeking public equity financing. Its first trading session occurred on 30 August 2007. The market was designed in the tradition of alternative and junior equity markets rather than as a direct duplicate of the WSE's principal regulated market. Its reference models included the United Kingdom's Alternative Investment Market and the Nordic First North markets. The underlying policy rationale was to make the public market more accessible to companies that might be too small, too young, or insufficiently mature for a conventional main-market flotation. NewConnect therefore offered a framework with lower costs for issuers, simplified admission requirements, and more limited reporting obligations than the WSE main market. In return, the market's issuer base could include businesses with shorter histories, less established commercial models, and lower trading liquidity. This gave investors access to earlier-stage opportunities but also required greater attention to company-specific risk. NewConnect operates as a multilateral trading facility outside the regulated market. The Warsaw Stock Exchange organises and operates the venue, while the broader ecosystem includes listed issuers, investors, brokers, and authorised advisers involved in admissions and continuing compliance. The market's role is not limited to initial fundraising: it also provides a venue for secondary trading and can serve as a transition point for companies that later pursue a main-market listing. The market has been particularly relevant to Polish small and medium-sized enterprises and to sectors associated with innovation and growth. Its issuer population has included companies from technology, pharmaceutical, biotechnology, and other emerging industries. The market also supports performance measurement through dedicated indices. NCIndex provides a broad measure of NewConnect-listed companies, while NSX Life Science focuses on issuers in pharmaceutical and biotechnology fields. By November 2021, the cited reference recorded 376 listed companies and market capitalisation of PLN 18.862 billion. It stated that almost all listed companies were Polish, with four foreign companies. These data describe the market at that historical point and do not establish its present size. NewConnect's history reflects the broader evolution of Poland's capital markets toward a more differentiated financing structure. The WSE main market remains the venue for larger and more established issuers, while NewConnect provides an alternative route for businesses at an earlier stage of development. Its importance lies in lowering the practical threshold for public financing, creating a market record for growing companies, and potentially preparing issuers for later migration to a regulated exchange segment. At the same time, the simplified framework makes the market distinct from, rather than equivalent to, a mature regulated exchange: issuer quality, liquidity, volatility, and information availability may vary substantially across constituents.

• 2021

  Reported scale of the market

  [1]NewConnecten.wikipedia.org

  A November 2021 reference reported 376 listed companies and aggregate market capitalisation of PLN 18.862 billion.

• 2007

  First NewConnect trading session

  [1]NewConnecten.wikipedia.org

  NewConnect opened for trading on 30 August 2007 as an alternative equity market operated by the Warsaw Stock Exchange.

A junior equity market and multilateral trading facility designed to provide smaller, younger, and growth-oriented companies with comparatively accessible public-market financing and trading.

• Alternative equity market · 2007

  NewConnect equity market

  The core NewConnect venue is a multilateral trading facility for shares of smaller and growth-oriented companies. It is operated by the Warsaw Stock Exchange outside the regulated market. Compared with the WSE main market, it is intended to provide a lower-cost and less complex route to public financing, with simplified admission criteria and more limited reporting requirements. The venue supports both the admission of new issuers and secondary trading in their shares.

• Equity market index

  NCIndex

  NCIndex is a broad performance indicator for companies listed on NewConnect. It is intended to provide a market-level reference for the performance of the alternative venue rather than representing a separate listing or trading platform.

• Sector equity index

  NSX Life Science

  NSX Life Science is an index focused on NewConnect companies operating in pharmaceutical and biotechnology sectors. It provides a sector-oriented view of listed life-science issuers within the NewConnect ecosystem.

• 2007

  Creation of an alternative market for smaller issuersProduct launch

  Background

  The Warsaw Stock Exchange sought to provide smaller and younger companies with a public financing route that was more accessible than the main regulated market.

  Action taken

  The WSE established NewConnect as a multilateral trading facility outside the regulated market, with comparatively lower costs, simplified admission criteria, and limited reporting requirements.

  Aftermath

  NewConnect held its first trading session on 30 August 2007 and became a dedicated venue for smaller growth companies.

  Source

1. 1NewConnecten.wikipedia.org
2. 2NewConnect official websitenewconnect.pl